- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Dimensional Fund Advisors Boosts Bristol Myers Squibb Stake
Institutional investor increases holdings in pharmaceutical company by 11.5% in Q3
Published on Mar. 4, 2026
Got story updates? Submit your updates here. ›
Dimensional Fund Advisors LP, a major institutional investor, increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 11.5% in the third quarter of 2026, according to a recent 13F filing with the Securities and Exchange Commission (SEC). The fund now owns 18,143,672 shares of the biopharmaceutical company's stock, valued at approximately $818 million.
Why it matters
Dimensional Fund Advisors is a respected institutional investor, and its increased stake in Bristol Myers Squibb suggests confidence in the pharmaceutical company's long-term prospects. This news could signal positive sentiment among institutional investors towards Bristol Myers Squibb's drug pipeline and financial performance.
The details
According to the 13F filing, Dimensional Fund Advisors purchased an additional 1,873,618 shares of Bristol Myers Squibb during the third quarter, bringing its total ownership to approximately 0.89% of the company's outstanding shares. The investment firm is known for its data-driven, systematic approach to investing, and its increased position in Bristol Myers Squibb may indicate the company's alignment with Dimensional's investment criteria.
- Dimensional Fund Advisors increased its stake in Bristol Myers Squibb during the third quarter of 2026.
The players
Dimensional Fund Advisors LP
A global investment management firm that uses a systematic, data-driven approach to investing.
Bristol Myers Squibb Company
A leading biopharmaceutical company focused on developing and delivering innovative medicines for serious diseases.
The takeaway
Dimensional Fund Advisors' increased stake in Bristol Myers Squibb suggests institutional confidence in the pharmaceutical company's long-term prospects, which could be a positive signal for investors considering the stock.
